mu

House Likely To Pass USD 1.9 Trillion COVID-19 Relief Bill

House Likely To Pass USD 1.9 Trillion COVID-19 Relief Bill

The House of Representatives will likely vote tomorrow to pass the much needed COVID-19 Relief/Stimulus Bill. After the bill was initially approved in the House, it was passed in the Senate by a paper thin 50-49 margin among party lines, with every ..

Starbucks Reports Earnings Amidst COVID-19 Pandemic

Starbucks Reports Earnings Amidst COVID-19 Pandemic

Starbucks Corporation (NASDAQ: SBUX) reported financial results for its 13-week fiscal second quarter ended March 29, 2020. The retailer of specialty coffee worldwide reported global comparable store sales declined 10%, driven by a 13% decrease in c..

Sprint and T Mobile Merge

Sprint and T Mobile Merge

T-Mobile US, Inc. (NASDAQ: TMUS) reported the completion of its merger with Sprint Corporation (NYSE: S) to form the new T-Mobile that will deliver the next generation 5G network.  T-Mobile’s common stock will continue to trade on NASDAQ..

iBio Provides Updates on COVID-19 Vaccine Program

iBio Provides Updates on COVID-19 Vaccine Program

iBio, Inc. (NYSE: IBIO) announced Thursday that immunization studies for its SARS-CoV-2 Virus-Like Particle (“VLP”) program (“IBIO-200”) are proceeding at Texas A&M University System (“TAMUS”) laboratories. Ac..

BioNTech and Fosun Pharma Announced Strategic Partnership on Potential COVID-19 Vaccine

BioNTech and Fosun Pharma Announced Strategic Partnership on Potential COVID-19 Vaccine

BioNTech SE (NASDAQ: BNTX) and Shanghai Fosun Pharmaceutical (Group) Co., Ltd (“Fosun Pharma” or “Group”; Stock Symbol: 600196.SH, 02196.HK) announced today a strategic development and commercialization collaboration to advan..

T-Mobile CEO Announces Future Plans

T-Mobile CEO Announces Future Plans

The German communications Company, Deutsche Telekom (XETRA: DTEG.DE), is aiming to become the market leader in the U.S. with its United States arm T-Mobile US, Inc. (NASDAQ: TMUS), which is on the finish line to take over Sprint (NYSE: S).The C..

Gilead Sciences Announced Licensing of Portfolio of HIV Antibodies

Gilead Sciences Announced Licensing of Portfolio of HIV Antibodies

Gilead Sciences, Inc. (NASDAQ: GILD) announced Thursday that it has licensed The Rockefeller University’s portfolio of broadly neutralizing antibodies (bNAbs) against HIV, including the two clinical-stage agents 3BNC117 and 10-1074. These inve..